Alternative strategies in newborns and infants with major co-morbidities to improve congenital heart surgery outcomes at an emerging programme

Cardiol Young. 2016 Mar;26(3):485-92. doi: 10.1017/S1047951115000463. Epub 2015 Jun 2.

Abstract

Introduction: Debilitating patient-related non-cardiac co-morbidity cumulatively increases risk for congenital heart surgery. At our emerging programme, flexible surgical strategies were used in high-risk neonates and infants generally considered in-operable, in an attempt to make them surgical candidates and achieve excellent outcomes.

Materials and methods: Between April, 2010 and November, 2013, all referred neonates (142) and infants (300) (average scores: RACHS 2.8 and STAT 3.0) underwent 442 primary cardiac operations: patients with bi-ventricular lesions underwent standard (n=294) or alternative (n=19) repair/staging strategies, such as pulmonary artery banding(s), ductal stenting, right outflow patching, etc. Patients with uni-ventricular hearts followed standard (n=96) or alternative hybrid (n=34) staging. The impact of major pre-operative risk factors (37%), standard or alternative surgical strategy, prematurity (50%), gestational age, low birth weight, genetic syndromes (23%), and major non-cardiac co-morbidity requiring same admission surgery (27%) was analysed on the need for extracorporeal membrane oxygenation, mortality, length of intubation, as well as ICU and hospital length of stays.

Results: The need for extracorporeal membrane oxygenation (8%) and hospital survival (94%) varied significantly between surgical strategy groups (p=0.0083 and 0.028, respectively). In high-risk patients, alternative bi- and uni-ventricular strategies minimised mortality, but were associated with prolonged intubation and ICU stay. Major pre-operative risk factors and lower weight at surgery significantly correlated with prolonged intubation, hospital length of stay, and mortality.

Discussion: In our emerging programme, flexible surgical strategies were offered to 53/442 high-risk neonates and infants with complex CHDs and significant non-cardiac co-morbidity, in order to buffer risk and achieve patient survival, although at the cost of increased resource utilisation.

Keywords: CHD; intensive care; neonates; outcomes.

MeSH terms

  • Comorbidity
  • Female
  • Gestational Age
  • Heart Defects, Congenital / surgery*
  • Hospital Mortality*
  • Humans
  • Infant
  • Infant, Low Birth Weight*
  • Infant, Newborn
  • Infant, Premature*
  • Intensive Care Units
  • Length of Stay
  • Linear Models
  • Male
  • Mississippi
  • Risk Factors
  • Treatment Outcome
  • Vascular Surgical Procedures / adverse effects*